Traders purchased shares of Clorox Company (The) (NYSE:CLX) on weakness during trading hours on Thursday. $42.82 million flowed into the stock on the tick-up and $28.19 million flowed out of the stock on the tick-down, for a money net flow of $14.63 million into the stock. Of all equities tracked, Clorox had the 30th highest net in-flow for the day. Clorox traded down ($0.81) for the day and closed at $144.24

CLX has been the topic of several recent analyst reports. Jefferies Group reissued a “hold” rating and set a $137.00 target price (up previously from $136.00) on shares of Clorox in a report on Wednesday, August 9th. BMO Capital Markets reissued an “outperform” rating on shares of Clorox in a report on Tuesday, September 12th. Zacks Investment Research cut Clorox from a “hold” rating to a “sell” rating in a report on Wednesday, October 4th. Royal Bank Of Canada reissued a “hold” rating and set a $115.00 target price on shares of Clorox in a report on Sunday, October 8th. Finally, Morgan Stanley dropped their target price on Clorox from $138.00 to $128.00 and set an “equal weight” rating on the stock in a report on Thursday, November 2nd. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the stock. Clorox presently has a consensus rating of “Hold” and a consensus target price of $128.72.

The company has a market cap of $18,652.26, a price-to-earnings ratio of 26.07, a P/E/G ratio of 3.93 and a beta of 0.43. The company has a debt-to-equity ratio of 3.02, a current ratio of 1.10 and a quick ratio of 0.77.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.41 by $0.05. The firm had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.48 billion. Clorox had a net margin of 11.84% and a return on equity of 161.59%. The firm’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.36 earnings per share. sell-side analysts expect that Clorox Company will post 5.6 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be given a $0.84 dividend. The ex-dividend date is Tuesday, January 23rd. This represents a $3.36 annualized dividend and a yield of 2.33%. Clorox’s dividend payout ratio (DPR) is 61.88%.

In other Clorox news, SVP Michael R. Costello sold 10,574 shares of Clorox stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total value of $1,438,169.74. Following the transaction, the senior vice president now owns 34,867 shares in the company, valued at $4,742,260.67. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Matthew T. Laszlo sold 20,051 shares of Clorox stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total transaction of $2,615,853.46. Following the completion of the transaction, the senior vice president now owns 10,896 shares in the company, valued at approximately $1,421,492.16. The disclosure for this sale can be found here. Insiders own 1.00% of the company’s stock.

A number of institutional investors have recently bought and sold shares of the business. Parkside Financial Bank & Trust grew its position in Clorox by 3.8% during the 2nd quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock worth $107,000 after purchasing an additional 29 shares in the last quarter. Valley National Advisers Inc. grew its position in Clorox by 0.6% during the 2nd quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock worth $115,000 after purchasing an additional 5 shares in the last quarter. Sun Life Financial INC grew its position in Clorox by 10,344.4% during the 2nd quarter. Sun Life Financial INC now owns 940 shares of the company’s stock worth $125,000 after purchasing an additional 931 shares in the last quarter. Blue Chip Partners Inc. grew its position in Clorox by 3.9% during the 2nd quarter. Blue Chip Partners Inc. now owns 941 shares of the company’s stock worth $125,000 after purchasing an additional 35 shares in the last quarter. Finally, Acrospire Investment Management LLC purchased a new position in Clorox during the 2nd quarter worth approximately $133,000. Hedge funds and other institutional investors own 73.42% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Investors Buy Clorox (CLX) on Weakness” was posted by Watch List News and is the property of of Watch List News. If you are viewing this article on another website, it was stolen and republished in violation of US & international copyright and trademark laws. The original version of this article can be read at https://www.watchlistnews.com/investors-buy-clorox-clx-on-weakness/1750391.html.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.